• Lung Cancer Prevention Trial Progress and PCI Pharma Services Manufacturing Agreement

    Press Release, January 29, 2019

    by VisionGate

    January 29,2019

    NewsResearch

  • Cellular Imaging Platform Detects the Presence of Cancer-Associated Cells that have undergone Malignancy Associated Change

    Press Release, April 16, 2018

    by VisionGate

    April 16,2018

    Research

  • VisionGate Lung Cancer 3D Cellular Imaging Research to be Featured as a Late-Breaking Abstract at the AACR Annual Meeting 2018

    Press Release, April 12, 2018

    by VisionGate

    April 12,2018

    NewsResearch

  • VisionGate is Leveraging the Cell-CT™ Platform to Expand Cancer Diagnostics Services

    Press Release, April 5, 2018

    by VisionGate

    April 5,2018

    NewsResearch

  • New Research Study Demonstrates Applicability of 3-D Cell-CT™ Imaging and Analysis Platform

    Press Release, December 12, 2017

    by VisionGate

    December 12,2017

    NewsPublicationsResearch

  • Advances in Lung Cancer Early Detection and Treatment at the World Conference on Lung Cancer

    Press Release, October 19, 2017

    by VisionGate

    October 6,2017

    NewsResearch

  • Blinded Trial Data Could Help Alleviate Worry Over Incidental Lung Nodule Findings

    VisionGate Presents Blinded Trial Data at WCLC 2016

    by VisionGate

    December 16,2016

    NewsResearch

  • LuCED Test and New Drug Therapy to Prevent Lung Cancer

    Demonstrate Promise in National Surveys of Pulmonologists  

    by VisionGate

    June 1,2016

    NewsResearch

  • Lung Cancer Pioneers Create Lung Cancer Eradication Pact

    Partnership Would Combine Company’s Patented Technology that Detects Pre-cancer of the Lungs with Drug Treatment that Prevents Cancer  

    by VisionGate

    January 7,2016

    Research

  • VisionGate’s LuCED Shows Promise for Lung Cancer Screening

    Blinded Trial Results Released at WCLC2015    

    by VisionGate

    September 11,2015

    NewsResearch

  • New Data Demonstrates VisionGate’s LuCED® Test Able to Detect Early Cancer

    Early Cancer Detection Even From Small Nodules

    by VisionGate

    November 20,2014

    NewsResearch

  • New Study Shows High Sensitivity and Specificity for LuCED® Test to Help Detect Lung Cancer Earlier

    Data to be Presented at ASCO 2014 Demonstrates that Non-Invasive LuCED Test Detects Stage I and II Lung Cancer       [...]

    by VisionGate

    May 15,2014

    Research

  • VisionGate Presents Clinical Data at IASLC Meeting

    VisionGate Presents Clinical Data at IASLC Meeting Showing its Cell-CT 3D Imaging Platorm detects Lung Cancer with High Sensitivity and Specificity

    by VisionGate

    October 28,2013

    Research

  • Adjunctive use of its 3D cell imaging platform can increase utility of CT screening for Lung Cancer

    IASLC_Press_Release_063011_FINAL_FOR WEBSITE POSTING

    by VisionGate

    October 15,2013

    NewsPublicationsResearch

  • Game Changer for Lung Cancer Announced

    NATIONAL EXPERT PANEL RECOMMENDS ANNUAL CT SCANS FOR THOSE AT HIGH RISK FOR LUNG CANCER; PUBLIC AND PRIVATE REIMBURSEMENTS EXPECTED TO FOLLOW [...]

    by VisionGate

    August 7,2013

    Research

  • VisionGate reports advances in it’s Cell-CT 3D cell analysis platform

    VisionGate reports advances in it's Cell-CT automated 3D cell analysis platform at ASC 2012 Scientific Meeting

    by VisionGate

    January 18,2013

    NewsResearch

  • Columnar Cell

    The cell is shown in maximum intensity projection. In the center and right panels, color and opacity have been adjusted to render [...]

    by VisionGate

    May 17,2011

    Research

  • Adenocarcinoma

    The cell is shown in maximum intensity projection. In the center and right panels, color and opacity have been adjusted to render [...]

    by VisionGate

    May 17,2011

    Research

  • Cell-CT

    The Cell-CT™ uses a technique called Optical Projection Tomography to render cells in 3D. This process is illustrated in the video where [...]

    by VisionGate

    May 17,2011

    Research

  • Patients FAQ’s

    Learn more about our LuCED® lung test, VisionGate’s non-invasive diagnostic test to aid physicians in the early detection of lung cancer.

    by VisionGate

    April 24,2011

    Diagnostic TestsResearch

  • Physicians FAQ’s

    The LuCED® lung test is a non-invasive, cost-effective test to precede, supplement or follow low-dose CT scans.

    by VisionGate

    April 23,2011

    Diagnostic TestsResearch

  • Researchers FAQ’s

    VisionGate has ongoing research opportunities and continues to grow its team of collaborative partners from around the world.

    by VisionGate

    April 21,2011

    Diagnostic TestsResearch

  • Diagnostics Pipeline

    VisionGate is developing the sputum-based LuCED test to aid in early detection of lung cancer.

    by VisionGate

    April 12,2011

    Diagnostic TestsResearch

  • LuCED test development at the 24th International Conference for Lung cancer screening

    Getting a Better Look at Lung Nodules: Cell Scan Delivers Images Without X-rays An Interview With Thomas Neumann, MD Author: Anita Shaffer [...]

    by VisionGate

    February 25,2011

    Research

  • The city of Phoenix is opening the world’s first biomedical 3D cellular imaging lab

    The Cell-CT™ research lab, located on the Phoenix Biomedical Campus in downtown Phoenix, is seeking proposals from researchers in universities and nonprofit organizations to utilize the Cell-CT™ imaging device.

    by VisionGate

    September 10,2010

    Research

  • VisionGate, Inc. announced five abstracts describing its Cell-CT™ system for 3D cellular imaging

    VisionGate, Inc. presented abstracts describing its Cell-CT system and the Lung Cell Evaluation Device test (LuCED), for early detection of lung cancer, at [...]

    by VisionGate

    August 24,2010

    NewsResearch

  • Peer-reviewed publication in Pattern Recognition demonstrates superiority of Cell-CT™

    Seattle, WA, September 29, 2008 – VisionGate, a privately held biomed/biotech company, today announced the publisher’s notification of acceptance of a study [...]

    by VisionGate

    September 29,2008

    NewsPublicationsResearch